Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Expanded Access Program for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic, for the Treatment of Serious Infections Caused by Staphylococcus Aureus.

Next Previous
Trial Profile

Expanded Access Program for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic, for the Treatment of Serious Infections Caused by Staphylococcus Aureus.

Status: Active, no longer recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 31 May 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs AP SA01 (Primary)
  • Indications Staphylococcal infections
  • Focus Expanded access; Therapeutic Use
  • Sponsors AmpliPhi Biosciences Corporation; Armata Pharmaceuticals

    • Most Recent Events

    • 24 May 2019 Status changed from recruiting to active, no longer recruiting.
    • 25 Mar 2019 Results presented in the AmpliPhi Biosciences Corporation media release.
    • 08 Oct 2018 According to an AmpliPhi Biosciences media release, the treatment was conducted under emergency protocols per the Australian Therapeutic Goods Administration's (TGA) Special Access Scheme (SAS).
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top